Companies › PROK
PROKIDNEY CORP (PROK)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001850270 · EDGAR filings · Updated 2026-07-06
PROKIDNEY CORP (PROK) has 69 institutional managers reporting positions valued at $76.4M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-10 — Initial insider ownership filed (Form 3)
- 2026-05-29 — Insider transaction reported (Form 4)
- 2026-05-29 — Insider transaction reported (Form 4)
- 2026-05-29 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PROKIDNEY CORP has 69 institutional holders.
Insider activity
Insiders reported 14 transactions (7 buys, 5 sells) across 4 reporting insiders, with a net reported value of −$673.3K.
Data flags from SEC filings
Related companies
STEREOTAXIS INC (STXS) · PROMIS NEUROSCIENCES INC (PMN) · APYX MEDICAL CORPORATION (APYX) · AN2 Therapeutics Inc (ANTX) · SANUWAVE HEALTH INC (SNWV) · NOVABRIDGE BIOSCIENCES (NBP)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.